Yabao Pharmaceutical Group Co Ltd (600351) — Free Cash Flow Generation Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Free Cash Flow Generation Index of 0.94x as of September 2025. Free cash flow of CN¥121.90 Million represents 1% of operating cash flow (CN¥129.49 Million). Explore capital reinvestment ratio of Yabao Pharmaceutical Group Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Yabao Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2001–2024)
Historical FCF Generation Index trend for Yabao Pharmaceutical Group Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see Yabao Pharmaceutical Group Co Ltd (600351) cash conversion ratio.
Annual Free Cash Flow Generation for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year Free Cash Flow Generation Index for Yabao Pharmaceutical Group Co Ltd. Check Yabao Pharmaceutical Group Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.93x | CN¥437.03 Million | CN¥471.69 Million | CN¥34.66 Million | ▲ +15.9% |
| 2023 | 0.80x | CN¥397.70 Million | CN¥497.55 Million | CN¥99.86 Million | ▼ -7.6% |
| 2022 | 0.86x | CN¥398.23 Million | CN¥460.46 Million | CN¥62.23 Million | ▲ +10.5% |
| 2021 | 0.78x | CN¥342.45 Million | CN¥437.50 Million | CN¥95.05 Million | ▼ -6.3% |
| 2020 | 0.83x | CN¥318.09 Million | CN¥380.96 Million | CN¥62.87 Million | ▲ +32.4% |
| 2019 | 0.63x | CN¥268.08 Million | CN¥425.17 Million | CN¥157.09 Million | ▼ -25.0% |
| 2018 | 0.84x | CN¥358.59 Million | CN¥426.60 Million | CN¥68.01 Million | ▲ +117.9% |
| 2017 | 0.39x | CN¥62.38 Million | CN¥161.73 Million | CN¥99.34 Million | ▼ -15.9% |
| 2016 | 0.46x | CN¥71.49 Million | CN¥155.95 Million | CN¥84.46 Million | ▲ +57.4% |
| 2015 | 0.29x | CN¥41.79 Million | CN¥143.47 Million | CN¥101.68 Million | ▲ +987.2% |
| 2014 | 0.03x | CN¥4.79 Million | CN¥178.63 Million | CN¥173.84 Million | ▲ +103.6% |
| 2013 | -0.74x | CN¥-42.21 Million | CN¥56.80 Million | CN¥99.02 Million | ▲ +61.6% |
| 2011 | -1.94x | CN¥-78.83 Million | CN¥40.73 Million | CN¥119.56 Million | ▲ +78.7% |
| 2010 | -9.09x | CN¥-168.74 Million | CN¥18.57 Million | CN¥187.30 Million | ▼ -3492.4% |
| 2009 | 0.27x | CN¥98.74 Million | CN¥368.56 Million | CN¥269.82 Million | ▲ +161.7% |
| 2008 | -0.43x | CN¥-44.66 Million | CN¥102.90 Million | CN¥147.56 Million | ▼ -161.7% |
| 2007 | 0.70x | CN¥74.38 Million | CN¥105.69 Million | CN¥31.31 Million | ▲ +125.4% |
| 2006 | -2.77x | CN¥-32.10 Million | CN¥11.59 Million | CN¥43.70 Million | ▲ +11.4% |
| 2005 | -3.13x | CN¥-82.56 Million | CN¥26.40 Million | CN¥108.95 Million | ▼ -102.6% |
| 2004 | -1.54x | CN¥-123.09 Million | CN¥79.73 Million | CN¥202.81 Million | ▼ -1114.0% |
| 2002 | -0.13x | CN¥-3.09 Million | CN¥24.29 Million | CN¥27.38 Million | ▼ -650.2% |
| 2001 | 0.02x | CN¥545.20K | CN¥23.59 Million | CN¥23.04 Million | — |